Capo Therapeutics

Capo Therapeutics is a company that provides vaccine therapies for debilitating diseases of the brain. It is engaged in the development of a vaccine enabling the treatment of Alzheimer’s disease. The company uses a technology platform that targets appropriate pathological molecules, such as Aβ, tau, α-syn, and their combinations at specific disease stages.